White House releases economic analysis of Trump's pharmaceutical pricing deals
Photo: PBS NewsHour
Economy Added 47d ago 4 outlets

White House releases economic analysis of Trump's pharmaceutical pricing deals

White House economists released projections estimating that President Trump's deals with pharmaceutical companies to align U.S. drug prices with international levels could save $529 billion economy-wide over 10 years, with $64.3 billion in combined federal and state Medicaid savings. The analysis, obtained by AP, provides the first detailed economic backing for a policy Trump is promoting ahead of midterm elections. Democratic lawmakers have expressed skepticism about the savings figures.

12
Divergence score
4 outlets covered it, splitting into 4 framing camps across 2 bias groups.
4 camps
2 bias groups
The spectrum · how 4 outlets placed this story
LeftCenterRight
PBS NewsHour
ABC News
AP News
Reuters
Horizontal = outlet biasColor = this story's framing
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
The split, in one line
PBS, ABC, and AP emphasized the $529 billion economy-wide projection and Democratic skepticism as headline. Reuters led with the $64.3 billion Medicaid savings figure and framed it as a Trump administration announcement, not White House analysis.
How each outlet covered it

Only the left is covering this

One side of the spectrum has stayed silent. That absence is itself a signal.

THE LEFT1 outlet · mostly neutral
Trump's drugmaker deals may save economy $529B over 10 years, White House says
ABC ABC News LEFT-CENTER
0RIGHT OUTLETS
0
RIGHT OUTLETS
0 of 4 outlets covering this story sit on that side of the spectrum.
DOWN THE MIDDLE

“Trump's drugmaker deals may save economy $529B over 10 years, White House says” · PBS NewsHour, AP News, Reuters

+Hide the full sourcingSee how all 4 outlets put it
Tracked claims from across the political spectrum
Fact ledger
Corroborated
Disputed